16/02/2023
Mingwood Biotechnology Beijing, Ltd. s seeking global business opportunities.
At Mingwood, our purpose is simple: to make cutting-edge medical devices accessible to everyone.
Our business consists of three parts: diagnosis for women and children, mass spectrum, and orthopedics. In 2000, we began as a manufacturer of in-vitro diagnostic products, creating the BV Rapid Blue TM test reagent for gynecology, which became the first product of its kind to receive approval in China. Over time, we expanded our product line to include HPV, TCT, prenatal diagnosis, newborn screening, and other offerings. Additionally, as a distributor, we have built a robust national sales network for orthopedic products. Our company is known for delivering high-quality trauma, joint, and spine implants and consumables to some of the most prominent hospitals in the country. In 2019, we saw rapid adoption of mass-spectrum medical solutions in hospitals, and we seized the opportunity to enter this market. Since then, we have had more than 60 types of mass spectrum tests in the market.
As the domestic market has saturated, our company is seeking global business opportunities.
In everything we do, we are dedicated to the faith of our vision: Low-cost healthcare for everyone, through the power of technology and innovation.
